{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:07:08Z","timestamp":1791184028501,"version":"4.1.0"},"reference-count":28,"publisher":"American Association for Cancer Research (AACR)","issue":"8","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The role of placenta growth factor (PlGF) in pathologic angiogenesis is controversial. The effects of PlGF on growth, angiogenesis, and metastasis from orthotopic tumors are not known. To this end, we stably transfected three human cancer cell lines (A549 lung, HCT116 colon, and U87-MG glioblastoma) with human plgf-2 full-length cDNA. Overexpression of PlGF did not affect tumor cell proliferation or migration in vitro. The growth of PlGF-overexpressing tumors grown orthotopically or ectopically was impaired in all three tumor models. This decrease in tumor growth correlated with a decrease in tumor angiogenesis. The PlGF-overexpressing tumors had decreased vessel density and increased vessel diameter, but vessel permeability was not different from the parental tumors. Tumors overexpressing PlGF exhibited higher levels of PlGF homodimers and PlGF\/vascular endothelial growth factor (VEGF) heterodimers but decreased levels of VEGF homodimers. Our study shows that PlGF overexpression decreases VEGF homodimer formation and inhibits tumor progression. (Cancer Res 2006; 66(8): 3971-7)<\/jats:p>","DOI":"10.1158\/0008-5472.can-04-3085","type":"journal-article","created":{"date-parts":[[2006,4,17]],"date-time":"2006-04-17T16:20:21Z","timestamp":1145290821000},"page":"3971-3977","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Placenta Growth Factor Overexpression Inhibits Tumor Growth, Angiogenesis, and Metastasis by Depleting Vascular Endothelial Growth Factor Homodimers in Orthotopic Mouse Models"],"prefix":"10.1158","volume":"66","author":[{"given":"Lei","family":"Xu","sequence":"first","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Cochran","sequence":"additional","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky T.","family":"Tong","sequence":"additional","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Winkler","sequence":"additional","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kashiwagi","sequence":"additional","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Fukumura","sequence":"additional","affiliation":[{"name":"Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,4,17]]},"reference":[{"key":"2022061622140428800_B1","doi-asserted-by":"crossref","unstructured":"Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med\u20082001; 7: 575\u201383.","DOI":"10.1038\/87904"},{"key":"2022061622140428800_B2","doi-asserted-by":"crossref","unstructured":"Autiero M, Waltenberger J, Communi D, et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med\u20082003; 9: 936\u201343.","DOI":"10.1038\/nm884"},{"key":"2022061622140428800_B3","doi-asserted-by":"crossref","unstructured":"Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med\u20082002; 8: 831\u201340.","DOI":"10.1038\/nm731"},{"key":"2022061622140428800_B4","doi-asserted-by":"crossref","unstructured":"Eriksson A, Cao R, Pawliuk R, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1\/VEGF heterodimers. Cancer Cell\u20082002; 1: 99\u2013108.","DOI":"10.1016\/S1535-6108(02)00028-4"},{"key":"2022061622140428800_B5","doi-asserted-by":"crossref","unstructured":"Bjorndahl M, Cao R, Eriksson A, et al. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion. Circ Res\u20082004; 94: 1443\u201350.","DOI":"10.1161\/01.RES.0000129194.61747.bf"},{"key":"2022061622140428800_B6","doi-asserted-by":"crossref","unstructured":"Xu L, Fukumura D, Jain RK. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1\/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem\u20082002; 277: 11368\u201374.","DOI":"10.1074\/jbc.M108347200"},{"key":"2022061622140428800_B7","unstructured":"Morikawa K, Walker SM, Nakajima M, et al. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res\u20081988; 48: 6863\u201371."},{"key":"2022061622140428800_B8","doi-asserted-by":"crossref","unstructured":"Yuan F, Chen Y, Dellian M, et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor\/vascular permeability factor antibody. Proc Natl Acad Sci U S A\u20081996; 93: 14765\u201370.","DOI":"10.1073\/pnas.93.25.14765"},{"key":"2022061622140428800_B9","doi-asserted-by":"crossref","unstructured":"Xu L, Fidler IJ. Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res\u20082000; 12: 97\u2013106.","DOI":"10.3727\/096504001108747567"},{"key":"2022061622140428800_B10","doi-asserted-by":"crossref","unstructured":"Baker CH, Kedar D, McCarty MF, et al. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol\u20082002; 161: 929\u201338.","DOI":"10.1016\/S0002-9440(10)64253-8"},{"key":"2022061622140428800_B11","unstructured":"Yuan F, Leunig M, Huang SK, et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res\u20081994; 54: 3352\u20136."},{"key":"2022061622140428800_B12","doi-asserted-by":"crossref","unstructured":"Yuan F, Leunig M, Berk DA, et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res\u20081993; 45: 269\u201389.","DOI":"10.1006\/mvre.1993.1024"},{"key":"2022061622140428800_B13","doi-asserted-by":"crossref","unstructured":"Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer\u20082002; 2: 266\u201376.","DOI":"10.1038\/nrc778"},{"key":"2022061622140428800_B14","doi-asserted-by":"crossref","unstructured":"Selvaraj SK, Giri RK, Perelman N, et al. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood\u20082003; 102: 1515\u201324.","DOI":"10.1182\/blood-2002-11-3423"},{"key":"2022061622140428800_B15","doi-asserted-by":"crossref","unstructured":"Khurana R, Moons L, Shafi S, et al. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation\u20082005; 111: 2828\u201336.","DOI":"10.1161\/CIRCULATIONAHA.104.495887"},{"key":"2022061622140428800_B16","doi-asserted-by":"crossref","unstructured":"Han H, Silverman JF, Santucci TS, et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol\u20082001; 8: 72\u20139.","DOI":"10.1007\/s10434-001-0072-y"},{"key":"2022061622140428800_B17","doi-asserted-by":"crossref","unstructured":"Kondo S, Asano M, Matsuo K, et al. Vascular endothelial growth factor\/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta\u20081994; 1221: 211\u20134.","DOI":"10.1016\/0167-4889(94)90016-7"},{"key":"2022061622140428800_B18","doi-asserted-by":"crossref","unstructured":"DiSalvo J, Bayne ML, Conn G, et al. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer. J Biol Chem\u20081995; 270: 7717\u201323.","DOI":"10.1074\/jbc.270.13.7717"},{"key":"2022061622140428800_B19","doi-asserted-by":"crossref","unstructured":"Fong GH, Zhang L, Bryce DM, et al. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development\u20081999; 126: 3015\u201325.","DOI":"10.1242\/dev.126.13.3015"},{"key":"2022061622140428800_B20","doi-asserted-by":"crossref","unstructured":"Clark DE, Smith SK, He Y, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod\u20081998; 59: 1540\u20138.","DOI":"10.1095\/biolreprod59.6.1540"},{"key":"2022061622140428800_B21","unstructured":"Hiratsuka S, Maru Y, Okada A, et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res\u20082001; 61: 1207\u201313."},{"key":"2022061622140428800_B22","doi-asserted-by":"crossref","unstructured":"Landgren E, Schiller P, Cao Y, et al. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene\u20081998; 16: 359\u201367.","DOI":"10.1038\/sj.onc.1201545"},{"key":"2022061622140428800_B23","doi-asserted-by":"crossref","unstructured":"Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factor (VPF)\/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF\/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem\u20082001; 276: 26969\u201379.","DOI":"10.1074\/jbc.M103213200"},{"key":"2022061622140428800_B24","doi-asserted-by":"crossref","unstructured":"Rahimi N, Dayanir V, Lashkari K. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J Biol Chem\u20082000; 275: 16986\u201392.","DOI":"10.1074\/jbc.M000528200"},{"key":"2022061622140428800_B25","doi-asserted-by":"crossref","unstructured":"Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med\u20082001; 7: 1194\u2013201.","DOI":"10.1038\/nm1101-1194"},{"key":"2022061622140428800_B26","doi-asserted-by":"crossref","unstructured":"Lewis C, Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol\u20082005; 167: 627\u201335.","DOI":"10.1016\/S0002-9440(10)62038-X"},{"key":"2022061622140428800_B27","doi-asserted-by":"crossref","unstructured":"Odorisio T, Schietroma C, Zaccaria ML, et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci\u20082002; 115: 2559\u201367.","DOI":"10.1242\/jcs.115.12.2559"},{"key":"2022061622140428800_B28","doi-asserted-by":"crossref","unstructured":"Luttun A, Brusselmans K, Fukao H, et al. Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun\u20082002; 295: 428\u201334.","DOI":"10.1016\/S0006-291X(02)00677-0"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/8\/3971\/2560462\/3971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/8\/3971\/2560462\/3971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:42:09Z","timestamp":1655426529000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/8\/3971\/527243\/Placenta-Growth-Factor-Overexpression-Inhibits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,15]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2006,4,17]]},"published-print":{"date-parts":[[2006,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-04-3085","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,15]]}}}